BioConvergence pour la Santé (BioConvS) is a “Domaine d'Intérêt Majeur” (DIM) initiative from the Région Ile-de-France which aims to structure the synthetic biology, biotherapy and bioproduction communities, to guide the transition from scientific excellence to innovation, and to position Île-de-France region as an international reference in the domain.

BioConvS is led by Université Paris Cité in partnership with Sorbonne University, Curie Institute - PSL, Micalis Institute (INRAe, AgroParisTech, Saclay University), INSERM, Généthon, Génopole and others. BioConvS groups actors from the public and private sectors and benefits from 12.5M€ support from the Ile de France Region. More details about DIM BioConvS on: https://bioconvs.org/

This call will fund three postdoc allocations on projects at the interface between synthetic biology and health sciences, on either a fundamental or applied level. It will be open from January 17th, 2023 to March 13th, 2023. We will fund exclusively collaborations between two academic research teams from the Region Ile de France working on synthetic biology on one of the following axes of the DIM:

•     Life sciences engineering and bioproduction
•     Development of therapeutics proofs-of-principles
•     New, high throughput, standardisable analytical methods
•     Digital or AI tools to improve data analysis or modelling in quality control and production methods
•     Guarantee an inclusive, responsible, sustainable Bioconvergence

Additional teams can participate in the project to bring additional specific expertise without geographic limitation. Teams out of the region Ile de France will not be funded.

Start-ups and companies, ideally from the Ile de France region, can also be associated to the project without required funding. 

Projects have to be written in English, but a summary in French is required.

BioconvS website

Join our LinkedIn group

Les DIM de la Région Ile-de-France